A Phase 1/2a Study Evaluating the Effects of ARO-MMP7 Inhalation Solution in Healthy Subjects and Patients with Idiopathic Pulmonary Fibrosis

Status

Completed

Phases

Phase 1Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-504964-41-00

Acronym

AROMMP7-1001

Enrollment

Registered

2023-10-06

Start date

2024-11-06

Completion date

2025-07-30

Last updated

2025-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic pulmonary fibrosis

None listed

Sex/Gender

All

Age

18 Years to No maximum

Denmark, Italy, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026